- 1,372
- 1,826
Bought 2k, sold half for 6k. Holding the rest to see where it goes.
Trying to get in a better habit of locking in profits.
OFFICIAL STOCK MARKET AND ECONOMY THREAD VOL. A NEW CHAPTER
- Thread in 'General' Thread starter Started by johnnyredstorm,
- Start date
Bought 2k, sold half for 6k. Holding the rest to see where it goes.
Trying to get in a better habit of locking in profits.
- 28,231
- 12,584
TSLA is flirting with 1400.
アミーゴ
for President!
アミーゴ
for President!
- 40,319
- 45,057
- 2,624
- 2,618
They buying take2 already ? So they can convert NBA 2k back to Live ? LOLOLOL
- 621
- 1,151
Will sit on it for a while to avoid short term capital gains. Am tempted to cash out and buy myself and the wife new watches though. LOL
- 15,801
- 12,198
Can someone explain the fractions for me
is that stock options?
also i need that explained lol
is that stock options?
also i need that explained lol
- 586
- 595
Not too late to buy both Tesla or amazon? I have 50k to dump in both
- 74,923
- 24,339
Nah you can buy partial shares on a few different brokers.
Grabbed a few shares of SE right here in case it gaps up and runs over 115 back to highs. Will add around 109 if not.
Honestly none of us can answer that question for you. I personally would NOT use all of my money at this point, if I wanted to be a buyer. I'd DCA and build a position over time.
- 28,948
- 17,609
- 14,173
- 6,430
jjs see above, plz handle “???” - Bezos
Let’s ride babaaaaaay !!
- 2,328
- 2,078
Nasdaq looking like bitcoin 2.0
- 15,801
- 12,198
Sheet woke up an hr ago and all im thinking about is tesla
- 57,833
- 61,548
Seeing Tesla skyrocket like this hurts 
- 12,086
- 14,908
$NVAX 
Novavax +35% after scoring $1.6B in funding from Operation Warp Speed
The OWS award funds large-scale manufacturing of NVX-CoV2373, Novavax's COVID-19 vaccine candidate including production of 100M doses starting in late 2020.
That includes a pivotal Phase 3 clinical trial with up to 30,000 subjects beginning in the fall of 2020. A Phase 1/2 clinical trial of NVX-CoV2373 in 130 healthy participants 18 to 59 years of age began in Australia in May.
Preliminary immunogenicity and safety results are expected at the end of July, and the Phase 2 portion to assess immunity, safety, and COVID-19 disease reduction is expected to begin thereafter.
Novavax +35% after scoring $1.6B in funding from Operation Warp Speed
The OWS award funds large-scale manufacturing of NVX-CoV2373, Novavax's COVID-19 vaccine candidate including production of 100M doses starting in late 2020.
That includes a pivotal Phase 3 clinical trial with up to 30,000 subjects beginning in the fall of 2020. A Phase 1/2 clinical trial of NVX-CoV2373 in 130 healthy participants 18 to 59 years of age began in Australia in May.
Preliminary immunogenicity and safety results are expected at the end of July, and the Phase 2 portion to assess immunity, safety, and COVID-19 disease reduction is expected to begin thereafter.
- 57,833
- 61,548
Jesus fn Christ. This pandemic is making so many thousand and millionaires$NVAX
Novavax +35% after scoring $1.6B in funding from Operation Warp Speed
The OWS award funds large-scale manufacturing of NVX-CoV2373, Novavax's COVID-19 vaccine candidate including production of 100M doses starting in late 2020.
That includes a pivotal Phase 3 clinical trial with up to 30,000 subjects beginning in the fall of 2020. A Phase 1/2 clinical trial of NVX-CoV2373 in 130 healthy participants 18 to 59 years of age began in Australia in May.
Preliminary immunogenicity and safety results are expected at the end of July, and the Phase 2 portion to assess immunity, safety, and COVID-19 disease reduction is expected to begin thereafter.
- 12,086
- 14,908
- 74,923
- 24,339
Great job managing risk, raise your stop above your entry and you're set. Congrats man.
LVGO raises revenue guidance by 10 mill. Stock exploding premarket.
- 3,602
- 2,238
$NVAX
Novavax +35% after scoring $1.6B in funding from Operation Warp Speed
The OWS award funds large-scale manufacturing of NVX-CoV2373, Novavax's COVID-19 vaccine candidate including production of 100M doses starting in late 2020.
That includes a pivotal Phase 3 clinical trial with up to 30,000 subjects beginning in the fall of 2020. A Phase 1/2 clinical trial of NVX-CoV2373 in 130 healthy participants 18 to 59 years of age began in Australia in May.
Preliminary immunogenicity and safety results are expected at the end of July, and the Phase 2 portion to assess immunity, safety, and COVID-19 disease reduction is expected to begin thereafter.
damn. y didn't i get in?!!! i didn't realize how seasoned you were til recently otherwise i would've tailed this for sure haha
- 2,624
- 2,618
$NVAX
Novavax +35% after scoring $1.6B in funding from Operation Warp Speed
The OWS award funds large-scale manufacturing of NVX-CoV2373, Novavax's COVID-19 vaccine candidate including production of 100M doses starting in late 2020.
That includes a pivotal Phase 3 clinical trial with up to 30,000 subjects beginning in the fall of 2020. A Phase 1/2 clinical trial of NVX-CoV2373 in 130 healthy participants 18 to 59 years of age began in Australia in May.
Preliminary immunogenicity and safety results are expected at the end of July, and the Phase 2 portion to assess immunity, safety, and COVID-19 disease reduction is expected to begin thereafter.
Killing it!!! I remember you recommending this back in January when it was less than $9
- 2,328
- 2,078
1000% gain on nvax
time to go lose some of that...placing a sell order on tsla at 1450
time to go lose some of that...placing a sell order on tsla at 1450
- 3,602
- 2,238
- 2,328
- 2,078
Let’s talk in a few weeks.
I am only risking money I would not even notice losing.
I am only risking money I would not even notice losing.
- 9,732
- 15,820
Tesla hmm
- 74,923
- 24,339
Richard Chu
@richard_chu97
· 8m
Wow, I mentioned that $LVGO guidance seemed conservative, but I didn’t expect them to raise it this much! New guide at the top end implies 113% growth vs the 83% prior, and if they beat by the same margins as last qtr, then that’s 120% growth! A re-acceleration from 115% in Q1!
@richard_chu97
· 8m
Wow, I mentioned that $LVGO guidance seemed conservative, but I didn’t expect them to raise it this much! New guide at the top end implies 113% growth vs the 83% prior, and if they beat by the same margins as last qtr, then that’s 120% growth! A re-acceleration from 115% in Q1!
